Please assess the completion status of the following clinical trial:

Trial Title: SPD503 (Guanfacine Hydrochloride) in ADHD Plus Oppositional Symptoms

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy subjects with ADHD and oppositional symptoms~* ADHD-RS\>=24~* CGI \>=4~* T-score of Opp subscale CPRS-R:L \>=65~* Normal ECG and BP~* \>= 55 lbs

- Gender: ALL
- Minimum Age: 6 Years
- Maximum Age: 12 Years
- Healthy Volunteers: f

Study Arms:
- SPD503 (Guanfacine hydrochloride) (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).